Continuous glucose monitoring automatically tracks blood glucose levels, also called blood sugar, throughout the day and night. Continuous Glucose Monitoring (CGM) is a method to track glucose levels throughout the day and night. It tracks the measurements at regular intervals, 24 hours a day, and translate the readings into dynamic data, generating glucose direction and rate of change.
The U.S. diabetes population is one of the major factors leading to the growth of U.S. Continuous Glucose Monitoring Systems. For instance, according to the Centers for Disease Control and Prevention (CDC) & National Diabetes Statistics Reports, 2017, in 2015, diabetes was the seventh leading cause of death in the U.S. which was based on 79,535 death certificates in which diabetes was denoted as the underlying cause of death.
According to the Center for Disease Control and Prevention (CDC), 2015, 30.3 Mn Americans, 9.4% of the U.S. population have diabetes. The other 84.1 Mn have prediabetes, a condition that if not treated often leads to type 2 diabetes within five years.
The U.S. Continuous Glucose Monitoring (CGM) Devices Market was valued at $ XX Mn in 2018 and is forecast to grow at a XX% CAGR between 2018 and 2023, resulting in 2023 sales of $ XX. The market is driven by increasing pipeline products and favorable reimbursement policies by Center for Medicare & Medicaid Services (CMS) to strengthen the U.S. Continuous Glucose Monitoring Devices market, over the forecast period. For instance, companies such as Biorasis, Sano Intelligence, Nemaura Medical, Verily Lifesciences, are a few of the emerging companies which are expected to flourish the U.S. Continuous Glucose Monitoring market
The U.S. Continuous Glucose Monitoring (CGM) Devices Market is segmented on the basis of Component.
Based on the Component: Transmitter, Receiver, Sensor
The key players of the U.S. Continuous Glucose Monitoring (CGM) Devices Market are MedtronicDexcom, Seseonics, and Glysens
The report covers in-depth analysis of U.S. Continuous Glucose Monitoring (CGM) Devices Market. The report assesses the market products pipeline by stage of development (early development, pre-clinical, clinical and in approval), by component (Transmitter, Receiver, and Sensor). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.
The report includes in-depth company profiles of key players in U.S. Continuous Glucose Monitoring (CGM) Devices Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments.
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.
Data Collation (Primary & Secondary)
In-house Estimation (Based on proprietary databases and Models)
Market-related information is assembled from both primary and secondary sources.
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.